LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial.

de Koning, Marie-Sophie Ly / van Dorp, Paulien / Assa, Solmaz / Hartman, Minke Ht / Voskuil, Michiel / Anthonio, Rutger L / Veen, Duco / Pundziute-Do Prado, Gabija / Leiner, Tim / van Goor, Harry / van der Meer, Peter / van Veldhuisen, Dirk J / Nijveldt, Robin / Lipsic, Erik / van der Harst, Pim

American heart journal

2021  Volume 243, Page(s) 167–176

Abstract: Background: Ischemia and subsequent reperfusion cause myocardial injury in patients presenting with ST-segment elevation myocardial infarction (STEMI). Hydrogen sulfide (H: Study design: The Groningen Intervention study for the Preservation of ... ...

Abstract Background: Ischemia and subsequent reperfusion cause myocardial injury in patients presenting with ST-segment elevation myocardial infarction (STEMI). Hydrogen sulfide (H
Study design: The Groningen Intervention study for the Preservation of cardiac function with STS after STEMI (GIPS-IV) trial (NCT02899364) is a double-blind, randomized, placebo-controlled, multicenter trial, which will enroll 380 patients with a first STEMI. Patients receive STS 12.5 grams intravenously or matching placebo in addition to standard care immediately at arrival at the catheterization laboratory after providing consent. A second dose is administered 6 hours later at the coronary care unit. The primary endpoint is myocardial infarct size as quantified by cardiac magnetic resonance imaging 4 months after randomization. Secondary endpoints include the effect of STS on peak CK-MB during admission and left ventricular ejection fraction and NT-proBNP levels at 4 months follow-up. Patients will be followed-up for 2 years to assess clinical endpoints.
Conclusions: The GIPS-IV trial is the first study to determine the effect of a H
MeSH term(s) Humans ; Myocardial Infarction ; Percutaneous Coronary Intervention ; ST Elevation Myocardial Infarction/drug therapy ; Stroke Volume ; Thiosulfates ; Treatment Outcome ; Ventricular Function, Left
Chemical Substances Thiosulfates ; sodium thiosulfate (HX1032V43M)
Language English
Publishing date 2021-09-15
Publishing country United States
Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
ZDB-ID 80026-0
ISSN 1097-6744 ; 0002-8703
ISSN (online) 1097-6744
ISSN 0002-8703
DOI 10.1016/j.ahj.2021.08.012
Shelf mark
Ui IV Zs.15: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top